NCOIX
Price
$17.65
Change
-$0.01 (-0.06%)
Updated
Jul 31 closing price
Net Assets
568.12M
RITEX
Price
$9.71
Change
-$0.00 (-0.00%)
Updated
Jul 31 closing price
Net Assets
28.55B
Interact to see
Advertisement

NCOIX vs RITEX

NCOIX vs RITEX Comparison Chart in %
View a ticker or compare two or three
VS
NCOIX vs. RITEX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NCOIX is a Buy and RITEX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RITEX has more cash in the bank: 28.6B vs. NCOIX (568M). NCOIX pays higher dividends than RITEX: NCOIX (7.43) vs RITEX (6.40). NCOIX was incepted earlier than RITEX: NCOIX (16 years) vs RITEX (24 years). NCOIX (0.84) is less costly to investors than RITEX (0.70). NCOIX is a more actively managed with annual turnover of: 170.00 vs. RITEX (40.00). RITEX has a lower initial minimum investment than NCOIX: RITEX (250) vs NCOIX (100000). NCOIX annual gain was more profitable for investors over the last year : 6.62 vs. RITEX (5.11). NCOIX (25.43) and RITEX (24.70) have equivalent 5 years return.
NCOIXRITEXNCOIX / RITEX
Total Expense Ratio0.770.70110%
Annual Report Gross Expense Ratio0.840.70120%
Fund Existence16 years24 years-
Gain YTD2.6481.559170%
Front LoadN/AN/A-
Min. Initial Investment10000025040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets568M28.6B2%
Annual Yield % from dividends7.436.40116%
Returns for 1 year6.625.11130%
Returns for 3 years29.5128.02105%
Returns for 5 years25.4324.70103%
Returns for 10 years72.0475.1896%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSGFX25.680.18
+0.71%
Morgan Stanley Inst Global Franchise C
BRUHX19.050.07
+0.37%
MFS Blended Research Value Equity I
SUFCX42.530.03
+0.07%
NAA Mid Growth C
FSLZX54.870.04
+0.07%
Fidelity Advisor Stock Selec Mid Cp Z
TAMVX38.28-0.13
-0.34%
T. Rowe Price Mid-Cap Value Adv